Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?

Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?

Angiotensin II type-1 receptor antibody (AT1R-Ab) has been mooted as a potential effector of both acute and chronic antibody mediated rejection (AMR). A growing body of literature on the topic is now coming under scrutiny in the context of the evolving Banff AMR diagnostic classification system and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paul James Patrick Martin, Michelle Willicombe, Candice Roufosse
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Transplant International
Subjects:	AT1R antibody AT1R non-HLA antibody rejection antibody mediated rejection
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13280/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function
by: Tanusya Murali Murali, et al.
Published: (2024-12-01)

Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study
by: Zhiliang Guo, et al.
Published: (2025-01-01)

Immunoproteasome inhibition reduces donor specific antibody production and cardiac allograft vasculopathy in a mouse heart transplantation model
by: Allison M. Schwalb, et al.
Published: (2024-12-01)

Donor-Specific Antibodies Targeting a Repeated Eplet Mismatch and Outcome After Kidney Retransplantation
by: Caroline Arches, et al.
Published: (2024-11-01)

Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients
by: Gökce Yavuz, et al.
Published: (2025-01-01)

Network meta-analysis of pharmacological treatment for antibody-mediated rejection after organ transplantation
by: Junjie Sun, et al.
Published: (2024-12-01)

Contribution of long-lived plasma cells to antibody-mediated allograft rejection
by: Eunkyeong Jang, et al.
Published: (2024-12-01)

Role of microvascular pericyte dysfunction in antibody-mediated rejection following kidney transplantation
by: Jie Xu, et al.
Published: (2025-12-01)

Outcomes of ABO-incompatible kidney transplants with very high isoagglutinin titers: a single-center experience and literature review
by: Hamza Naciri Bennani, et al.
Published: (2024-12-01)

Shedding Light on Microvascular Inflammation: Understanding Outcomes, But What Sparks the Flame?
by: Louise Benning, et al.
Published: (2024-11-01)

Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center
by: Carmen Botella, et al.
Published: (2024-11-01)

Pre-transplant T-cell clonal analysis identifies CD8+ donor reactive clones that contribute to kidney transplant rejection
by: Jes M. Sanders, et al.
Published: (2025-02-01)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia
by: Marco Andreani, et al.
Published: (2017-03-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)

Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies
by: Gregor Rossmueller, et al.
Published: (2024-12-01)

Platelet antibody detection assays: a single-laboratory comparison of MAIPA, PIFT, and microsphere-based multiplex assays Pak-Lx
by: Thiago Henrique Costa, et al.
Published: (2024-11-01)

Case report: orthostatic hypotension as the first presentation of progressive encephalomyelitis with rigidity and myoclonus (PERM) with multiple autoimmune antibodies
by: Jinyi Song, et al.
Published: (2024-11-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01)

The Application of Machine Learning on Antibody Discovery and Optimization
by: Jiayao Zheng, et al.
Published: (2024-12-01)

Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II
by: Kevin A. Henry, et al.
Published: (2024-12-01)

Re-Evaluating the Transplant Glomerulopathy Lesion—Beyond Donor-Specific Antibodies
by: Arun Chutani, et al.
Published: (2024-11-01)

The EV antibody database: An interactive database of curated antibodies for extracellular vesicle and nanoparticle research
by: Amber Morey, et al.
Published: (2024-06-01)

Do antibody CDR loops change conformation upon binding?
by: Chu’nan Liu, et al.
Published: (2024-12-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Challenges in ABO-incompatible Renal Transplantation: A Case Report of Acute Antibody-mediated Rejection with Late Graft Thrombosis
by: Abhishek Pratap Singh, et al.
Published: (2024-12-01)

Plasmodium Falciparum and mosquito vector IgG patterns across suspected malaria cases in Ghana
by: Kwame Kumi Asare, et al.
Published: (2024-12-01)

What are clinically significant anti-drug antibodies and why is it important to identify them
by: Steven James Swanson
Published: (2024-12-01)

Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
by: Kun Du, et al.
Published: (2025-02-01)

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient
by: Mégane Tanguay, et al.
Published: (2025-12-01)

Advancements in Corneal Transplantation: Addressing Rejection Risks, Innovations and Challenges
by: Daria Ziemińska, et al.
Published: (2024-12-01)

Fibronectin in Immune Responses in Organ TransplantRecipients
by: Ana J. Coito, et al.
Published: (2000-01-01)

Clinical significance of unexpected antibody from IgG1 and IgG3 subtypes
by: LI Zhu, et al.
Published: (2024-11-01)

Current methods for detecting and assessing HIV-1 antibody resistance
by: Stanley Odidika, et al.
Published: (2025-01-01)

Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant
by: Lauren A. Ford-Siltz, et al.
Published: (2024-12-01)

Case report on anti-GQ1b antibody syndrome: initial symptoms of pupil palsy and periorbital pain
by: Yang Du, et al.
Published: (2024-12-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer
by: Julia Palecki, et al.
Published: (2024-12-01)